Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Find out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

Respiratory syncytial virus often mimics a common cold, but in older adults, this contagious virus can quickly lead to severe infections that may require hospitalisation and ICU admission Read ...

Respiratory Syncytial Virus is a common, contagious virus affecting the lungs and breathing passages.

Respiratory syncytial virus (RSV) causes symptoms similar to the common cold. But in older adults and those with certain medical conditions, the virus can increase the risk of serious illnesses.

Respiratory syncytial virus (RSV) infections can lead to serious complications, particularly in infants and older adults aged 75 years and above. Recent advancements in vaccine trials for older ...

New data for AREXVY, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatmen ...